Jean Wright, MD

Articles

Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions

Cesar Augusto Santa-Maria, MD;Melissa Camp, MD, MPH;Ashley Cimino-Mathews, MD;Susan Harvey, MD;Jean Wright, MD;Vered Stearns, MD

November 16th 2015

In this review, we will discuss multidisciplinary considerations in treating patients with neoadjuvant therapy and highlight areas of controversy and ongoing research.

Should Response to Preoperative Therapy Guide Local Management in Node-Positive Breast Cancer?

Jean Wright, MD;Jennifer R. Bellon, MD

September 15th 2015

Current data challenge the statement that recommendations for postmastectomy radiotherapy should be based on the highest clinical or pathologic stage. Instead, data suggest that in a majority of patients, the pathologic stage after neoadjuvant chemotherapy carries more prognostic value.